Related references
Note: Only part of the references are listed.Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
Daniel J. Brat et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2022)
A molecularly integrated grade for meningioma
Joseph Driver et al.
NEURO-ONCOLOGY (2022)
Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management
Elena Daoud et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)
A clinically applicable integrative molecular classification of meningiomas
Farshad Nassiri et al.
NATURE (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification
Giulia Berzero et al.
NEURO-ONCOLOGY (2021)
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria
C. Mircea S. Tesileanu et al.
NEURO-ONCOLOGY (2020)
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2020)
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading
David N. Louis et al.
BRAIN PATHOLOGY (2020)
Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study
Guillaume Gauchotte et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
Matthew Clarke et al.
CANCER DISCOVERY (2020)
A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas
F. Burel-Vandenbos et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
CDKN2A/Bhomozygous deletion is associated with early recurrence in meningiomas
Philipp Sievers et al.
ACTA NEUROPATHOLOGICA (2020)
cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors
David W. Ellison et al.
BRAIN PATHOLOGY (2020)
EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity
Aurore Siegfried et al.
BRAIN PATHOLOGY (2019)
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Zane Jaunmuktane et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates
David N. Louis et al.
BRAIN PATHOLOGY (2019)
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions
Damian Stichel et al.
ACTA NEUROPATHOLOGICA (2019)
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
Farshad Nassiri et al.
NEURO-ONCOLOGY (2019)
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Ana S. Guerreiro Stucklin et al.
NATURE COMMUNICATIONS (2019)
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
David Capper et al.
ACTA NEUROPATHOLOGICA (2018)
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2018)
Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zulch, the WHO ... and Shakespeare
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2017)
Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature
Rachael A. Vaubel et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
Kristian W. Pajtler et al.
CANCER CELL (2015)
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
Elizabeth Vera-Bolanos et al.
NEURO-ONCOLOGY (2015)
International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
David N. Louis et al.
BRAIN PATHOLOGY (2014)
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
David W. Ellison et al.
JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE (2011)
Share Paper
